Herpes simplex virus 2 (HSV-2) infected cell proteins are among the most dominant antigens of a live-attenuated HSV-2 vaccine.

Herpes simplex virus 2 (HSV-2) infected cell proteins are among the most dominant antigens of a live-attenuated HSV-2 vaccine.

Virion glycoproteins such as glycoprotein D (gD) are believed to be the dominant antigens of herpes simplex virus 2 (HSV-2). We have observed that mice immunized with a live HSV-2 ICP0- mutant virus, HSV-2 0ΔNLS, are 10 to 100 times better protected against genital herpes than mice immunized with a...

Full description

Bibliographic Details
Main Authors:	Joshua J Geltz, Edward Gershburg, William P Halford
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4319894?pdf=render

Similar Items

Assessment of Two Novel Live-Attenuated Vaccine Candidates for Herpes Simplex Virus 2 (HSV-2) in Guinea Pigs
by: Jonathan D. Joyce, et al.
Published: (2021-03-01)

A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine.
by: William P Halford, et al.
Published: (2011-03-01)

A herpes simplex virus 2 (HSV-2) glycoprotein D-expressing nonreplicating dominant-negative HSV-2 virus vaccine is superior to a gD2 subunit vaccine against HSV-2 genital infection in guinea pigs.
by: Pengwei Zhang, et al.
Published: (2014-01-01)

Immunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs
by: Brans Richard, et al.
Published: (2010-06-01)

Prevalence of Herpes Simplex Virus Type 1 and 2 (HSV-1 and HSV-2) in the Women with Breast Cancer by Multiplex-PCR method
by: Fatemeh Kaveh, et al.
Published: (2018-05-01)

The UL13 and US3 Protein Kinases of Herpes Simplex Virus 1 Cooperate to Promote the Assembly and Release of Mature, Infectious Virions.
by: Svetlana Gershburg, et al.
Published: (2015-01-01)

Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses
by: Brent A. Stanfield, et al.
Published: (2021-08-01)

Herpes Simplex Virus Mistyping due to HSV-1 × HSV-2 Interspecies Recombination in Viral Gene Encoding Glycoprotein B
by: Amanda M. Casto, et al.
Published: (2020-08-01)

Association between Herpes Simplex virus type 2 (HSV 2) and bad obstetric outcomes
by: Hala Mohamed Majeed Hassan, et al.
Published: (2014-01-01)

An Adenovirus-Based Recombinant Herpes Simplex Virus 2 (HSV-2) Therapeutic Vaccine Is Highly Protective against Acute and Recurrent HSV-2 Disease in a Guinea Pig Model
by: Mingming Wan, et al.
Published: (2023-01-01)

Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2.
by: William P Halford, et al.
Published: (2015-01-01)

The population impact of herpes simplex virus type 2 (HSV-2) vaccination on the incidence of HSV-2, HIV and genital ulcer disease in South Africa: a mathematical modelling studyResearch in context
by: Jack Stone, et al.
Published: (2023-04-01)

Reactivation of Herpes Simplex Virus (HSV) from Latency in Response to Neuronal Hyperexcitability
by: Sean Cuddy, et al.
Published: (2020-06-01)

Enhancement of Herpes Simplex Virus (HSV) Infection by Seminal Plasma and Semen Amyloids Implicates a New Target for the Prevention of HSV Infection
by: Lilith Torres, et al.
Published: (2015-04-01)

An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challenge.
by: Mariaconcetta Sicurella, et al.
Published: (2014-01-01)

Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women.
by: Peter B Gilbert, et al.
Published: (2017-01-01)

Use of "<it>biokit </it>HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA
by: Friedrich David, et al.
Published: (2005-10-01)

Optimal Control Strategy on the Transmission Dynamics of Herpes Simplex Virus-II (HSV-II)
by: Eshetu Dadi Gurmu, et al.
Published: (2021-01-01)

Earlier menarche is associated with a higher prevalence of Herpes simplex type-2 (HSV-2) in young women in rural Malawi
by: Judith R Glynn, et al.
Published: (2014-01-01)

Virus-specific immune memory at peripheral sites of herpes simplex virus type 2 (HSV-2) infection in guinea pigs.
by: Jingya Xia, et al.
Published: (2014-01-01)

Correction: Use of "biokitHSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA
by: Meier Amalia, et al.
Published: (2007-03-01)

The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment
by: Ifeanyi Kingsley Uche, et al.
Published: (2021-06-01)

Diagnosis and quantitative detection of HSV DNA in samples from patients with suspected herpes simplex encephalitis
by: Mazyar Ziyaeyan, et al.

Herpes Simplex Virus-type1 (HSV-1) Impairs DNA Repair in Cortical Neurons
by: Giovanna De Chiara, et al.
Published: (2016-10-01)

Diagnosis and quantitative detection of HSV DNA in samples from patients with suspected herpes simplex encephalitis
by: Mazyar Ziyaeyan, Ph.D., et al.
Published: (2011-05-01)

Protection of mice against lethal challenge with herpes simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B.
by: McDermott, MR, et al.
Published: (1989)

Multi-targeted loss of the antigen presentation molecule MR1 during HSV-1 and HSV-2 infection
by: Carolyn Samer, et al.
Published: (2024-02-01)

Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV.
by: David M J Houston, et al.
Published: (2017-01-01)

Correction: Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV.
by: David M J Houston, et al.
Published: (2017-01-01)

The Antiviral Potential of Iranian Herbal Pharmacopoeia (IHP) on Herpes Simplex Viruses (HSV): A Review Article
by: Shahin Gavanji
Published: (2022-07-01)

HSV-2-Specific Human Female Reproductive Tract Tissue Resident Memory T Cells Recognize Diverse HSV Antigens
by: David M. Koelle, et al.
Published: (2022-03-01)

A system for creating stable cell lines that express a gene of interest from a bidirectional and regulatable herpes simplex virus type 1 promoter.
by: Christopher B Chambers, et al.
Published: (2015-01-01)

HSV-2- and HIV-1- permissive cell lines co-infected by HSV-2 and HIV-1 co-replicate HSV-2 and HIV-1 without production of HSV-2/HIV-1 pseudotype particles
by: Bélec Laurent, et al.
Published: (2007-01-01)

HSV2 reactivation and myelitis following influenza vaccination
by: Allan Lieberman, et al.
Published: (2017-03-01)

Dynamics of HSV-2 infection with a therapeutic vaccine
by: Ezio Venturino, et al.
Published: (2020-07-01)

Seroprevalence of Herpes Simplex Virus type-2 (HSV-2) among pregnant women who participated in a national HIV surveillance activity in Haiti
by: Jean Wysler Domercant, et al.
Published: (2017-08-01)

Seroepidemiology of infection with Herpes Simplex Virus type 2 (HSV2) among asymptomatic students attending Islamic Azad University of Kazeroun, southwest of Iran
by: Tabatabaee Mojgan, et al.
Published: (2010-05-01)

Efficacy of Systemically Administered Retargeted Oncolytic Herpes Simplex Viruses—Clearance and Biodistribution in Naïve and HSV-Preimmune Mice
by: Andrea Vannini, et al.
Published: (2023-08-01)

Host Intrinsic and Innate Intracellular Immunity During Herpes Simplex Virus Type 1 (HSV-1) Infection
by: Thamir Alandijany, et al.
Published: (2019-11-01)

Incidental Detection of Hairy Cell Leukaemia with Herpes Simplex Virus (HSV) Related Lip Ulcer Mimicking Carcinoma
by: Pallavi Agrawal, et al.
Published: (2016-08-01)